GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL BTA) » Definitions » Valuation Rank

PharmaLundensis AB (XSAT:PHAL BTA) Valuation Rank


View and export this data going back to . Start your Free Trial

What is PharmaLundensis AB Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

PharmaLundensis AB Valuation Rank Related Terms

Thank you for viewing the detailed overview of PharmaLundensis AB's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaLundensis AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaLundensis AB (XSAT:PHAL BTA) » Definitions » Valuation Rank
Comparable Companies
XSAT:DBP B XSAT:RESP OSTO:SPRINT OSTO:NANECH OSTO:LPGO OSTO:STABL OSTO:SIMRIS B OSTO:QUIA OSTO:FLUI XSAT:APTA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
PHAL:Sweden
Address
PharmaLundensis AB, Scheelevagen 2, Lund, SWE, 223 63
Website
http://www.pharmalundensis.se
PharmaLundensis AB is a Sweden based drug manufacturing company, The company focuses on the development and marketing of pharmaceuticals. It is engaged in developing drugs for the lung diseases, such as chronic obstructive pulmonary disease and asthma, as well as drugs for mercury toxicology.